Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular Disease
MACHAON
1 other identifier
observational
53
1 country
1
Brief Summary
The aim is to evaluate the correlation of quantified fibro-adipous infiltration of muscles, using the MRI-based Mercuri score, with deficiencies, activity limitations and social participation in patients with arthrogryposis multiplex congenita.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 16, 2021
CompletedFirst Posted
Study publicly available on registry
November 30, 2021
CompletedNovember 30, 2021
November 1, 2021
1.6 years
November 16, 2021
November 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mercuri Scores of upper limbs, lower limbs,and trunk evaluated on MRI T1
The degree of muscle fat infiltration was assessed with at least 2 visible slices. We used the four-point scale proposed by Mercuri et al 2002. Each muscle was staged as follows: 1. Normal appearance, 2. Mild involvement. 3. Moderate involvement. 4. Severe involvement.
during 5 day evaluation
Secondary Outcomes (10)
muscle weakness
during 5 day evaluation
passive range of motion
during 5 day evaluation
6 minutes walking test
during 5 day evaluation
reaching score
during 5 day evaluation
Functionnal independance measure
during 5 day evaluation
- +5 more secondary outcomes
Study Arms (2)
Amyoplasia
patient with diagnosis of Amyoplasia
Distal arthrogryposis
patient with diagnosis of Distal arthrogryposis
Interventions
Eligibility Criteria
adults with a diagnostic of Amyoplasia or distal arthrogryposis, evaluated by a all body MRI, and functionnal evaluation during day hospitalisation in adult neurorehabilitation department of grenoble, between 2010 and october 2020
You may qualify if:
- adults
- with a diagnostic of Amyoplasia or distal arthrogryposis
- evaluated by a all body MRI
- functionnal evaluation during day hospitalisation in neurorehabilitation department
- between 2010 and october 2020
You may not qualify if:
- other aetiology of Arthrogryposis multiplex congenita (AMC)
- incomplete MRI or medical files
- interaction with other disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Grenoble Alpes
La Tronche, 38700, France
Related Publications (5)
Liu CY, Yao J, Kovacs WC, Shrader JA, Joe G, Ouwerkerk R, Mankodi AK, Gahl WA, Summers RM, Carrillo N. Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy. Neurology. 2021 Feb 2;96(5):e798-e808. doi: 10.1212/WNL.0000000000011231. Epub 2020 Nov 20.
PMID: 33219145BACKGROUNDHall JG. Arthrogryposis multiplex congenita: etiology, genetics, classification, diagnostic approach, and general aspects. J Pediatr Orthop B. 1997 Jul;6(3):159-66.
PMID: 9260643RESULTMercuri E, Pichiecchio A, Counsell S, Allsop J, Cini C, Jungbluth H, Uggetti C, Bydder G. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol. 2002;6(6):305-7. doi: 10.1016/s1090-3798(02)90617-3.
PMID: 12401454RESULTFigueroa-Bonaparte S, Segovia S, Llauger J, Belmonte I, Pedrosa I, Alejaldre A, Mayos M, Suarez-Cuartin G, Gallardo E, Illa I, Diaz-Manera J; Spanish Pompe Study Group. Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function. PLoS One. 2016 Oct 6;11(10):e0163493. doi: 10.1371/journal.pone.0163493. eCollection 2016.
PMID: 27711114RESULTDai S, Dieterich K, Jaeger M, Wuyam B, Jouk PS, Perennou D. Disability in adults with arthrogryposis is severe, partly invisible, and varies by genotype. Neurology. 2018 May 1;90(18):e1596-e1604. doi: 10.1212/WNL.0000000000005418. Epub 2018 Apr 6.
PMID: 29626181RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dominic PERENNOU, MDPHD
CHU Grenoble Alpes
- STUDY DIRECTOR
Klaus DIETERICH, MD
CHU Grenoble Alpes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2021
First Posted
November 30, 2021
Study Start
December 1, 2019
Primary Completion
July 1, 2021
Study Completion
October 1, 2021
Last Updated
November 30, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share